BPBenedikt Pregler

Benedikt Pregler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Benedikt Pregler has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Christian Stroszczynski

    Department of Radiology, University Medical Center of Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany

    1 shared publication
  • Christian Stroszczynski

    From the Institute of Radiology (Q.D.S., V.M., R.S., S.M., C.S., O.W.H.) and Department of Nuclear Medicine (S.H., D.S., J.G., D.H.), University of Regensburg Medical Center, Franz-Josef-Strauss-Allee 11, 93053 Regensburg, Germany; and Departments of Pulmonology (S.B.) and Radiology (O.W.H.), Donaustauf Hospital, Donaustauf, Germany

    1 shared publication
  • David Maintz

    Institute of Diagnostic and Interventional Radiology, Faculty of Medicine and University Hospital Cologne, Kerpener Str 62, 50937, Cologne, Germany

    1 shared publication
  • Ernst-Michael Jung

    Department of Radiology, University Medical Center of Regensburg, Franz-Josef-Strauß-Allee 11, 93053 Regensburg, Germany

    1 shared publication
  • Florian Poschenrieder

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    1 shared publication
  • Gregor Scharf

    Institut für Röntgendiagnostik, Universitätsklinikum Regensburg, Germany

    1 shared publication

Latest Publications

  • Radiology of COVID-19 Pneumonia – Pictorial Essay and Structured Reporting

    by Jan Schaible, Stefanie Meiler, Florian Poschenrieder, Gregor Scharf, David Maintz, Benedikt Pregler, Christian Stroszczynski, Okka Wilkea Hamer

    The novel coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)), which originated in China, has caused a worldwide pandemic [1]. The disease caused by SARS-CoV-2 is referred to as Coronavirus Disease 2019 (COVID-19). During the pandemic and probably beyond, radiologists performing CT examinations of patients with symptoms of a respiratory infection will inevitably be asked if it could be a case of COVID-19 pneumonia. On the other hand, if a chest CT performed for another indication yields abnormal results, the radiologist must consider the possibility of incidental COVID-19 pneumonia, communicate this to the referring physician as quickly as possible, and introduce the appropriate hygiene measures in his/her own department.


  • Open Access

    Continuous Dynamic Registration of Microvascularization of Liver Tumors with Contrast-Enhanced Ultrasound

    by Lukas Philipp Beyer, Benedikt Pregler, Isabel Wiesinger, Christian Stroszczynski, Philipp Wiggermann, Ernst-Michael Jung

    Aim.To evaluate the diagnostic value of quantification of liver tumor microvascularization using contrast-enhanced ultrasound (CEUS) measured continuously from the arterial phase to the late phase (3 minutes).Material and Methods.We present a retrospective analysis of 20 patients with malignant (n=13) or benign (n=7) liver tumors. The tumors had histopathologically been proven or clearly identified using contrast-enhanced reference imaging with either 1.5 T MRI (liver specific contrast medium) or triphase CT and follow-up. CEUS was performed using a multifrequency transducer (1–5 MHz) and a bolus injection of 2.4 mL sulphur hexafluoride microbubbles. A retrospective perfusion analysis was performed to determine TTP (time-to-peak), RBV (regional blood volume), RBF (regional blood flow), and Peak.Results.Statistics revealed a significant difference (P<0.05) between benign and malignant tumors in the RBV, RBF, and Peak but not in TTP (P=0.07). Receiver operating curves (ROC) were generated for RBV, RBF, Peak, and TTP with estimated ROC areas of 0.97, 0.96, 0.98, and 0.76, respectively.Conclusion.RBV, RBF, and Peak continuously measured over a determined time period of 3 minutes could be of valuable support in differentiating malignant from benign liver tumors.